The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Rebecca Brown Fountain; David R. Holmes; Krishnaswamy Chandrasekaran; Douglas Packer; Samuel Asirvatham; Robert Van Tassel; Zoltan Turi

doi:10.1016/j.ahj.2006.02.005

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Rebecca Brown Fountain, David R. Holmes, Krishnaswamy Chandrasekaran, Douglas Packer, Samuel Asirvatham, Robert Van Tassel, Zoltan Turi

Cardiovascular Medicine

Research output: Contribution to journal › Article › peer-review

151 Scopus citations

Abstract

The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

Original language	English (US)
Pages (from-to)	956-961
Number of pages	6
Journal	American heart journal
Volume	151
Issue number	5
DOIs	https://doi.org/10.1016/j.ahj.2006.02.005
State	Published - May 2006

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ahj.2006.02.005

Cite this

@article{b5af2db74d7c4d7c95a2ac42814ebbd6,

title = "The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial",

abstract = "The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.",

author = "Fountain, {Rebecca Brown} and Holmes, {David R.} and Krishnaswamy Chandrasekaran and Douglas Packer and Samuel Asirvatham and {Van Tassel}, Robert and Zoltan Turi",

year = "2006",

month = may,

doi = "10.1016/j.ahj.2006.02.005",

language = "English (US)",

volume = "151",

pages = "956--961",

journal = "American heart journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

AU - Fountain, Rebecca Brown

AU - Holmes, David R.

AU - Chandrasekaran, Krishnaswamy

AU - Packer, Douglas

AU - Asirvatham, Samuel

AU - Van Tassel, Robert

AU - Turi, Zoltan

PY - 2006/5

Y1 - 2006/5

N2 - The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

AB - The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

UR - http://www.scopus.com/inward/record.url?scp=33646081030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646081030&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2006.02.005

DO - 10.1016/j.ahj.2006.02.005

M3 - Article

C2 - 16644311

AN - SCOPUS:33646081030

SN - 0002-8703

VL - 151

SP - 956

EP - 961

JO - American heart journal

JF - American heart journal

IS - 5

ER -

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this